{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:10:01Z","timestamp":1781662201151,"version":"3.54.5"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"India Ministry of Science & Technology Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/MED\/30\/SP11006\/2015"],"award-info":[{"award-number":["BT\/MED\/30\/SP11006\/2015"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"India Ministry of Science & Technology Department of Science and Technology","doi-asserted-by":"publisher","award":["DST\/ICPS\/CPS-Individual\/2018\/279(G)"],"award-info":[{"award-number":["DST\/ICPS\/CPS-Individual\/2018\/279(G)"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008789","name":"Department of Science and Technology, Government of West Bengal","doi-asserted-by":"publisher","award":["phs000348.v1.p1"],"award-info":[{"award-number":["phs000348.v1.p1"]}],"id":[{"id":"10.13039\/501100008789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008789","name":"Department of Science and Technology, Government of West Bengal","doi-asserted-by":"publisher","award":["phs000748"],"award-info":[{"award-number":["phs000748"]}],"id":[{"id":"10.13039\/501100008789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008789","name":"Department of Science and Technology, Government of West Bengal","doi-asserted-by":"publisher","award":["phs000348"],"award-info":[{"award-number":["phs000348"]}],"id":[{"id":"10.13039\/501100008789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008789","name":"Department of Science and Technology, Government of West Bengal","doi-asserted-by":"publisher","award":["18964"],"award-info":[{"award-number":["18964"]}],"id":[{"id":"10.13039\/501100008789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001253","name":"Multiple Myeloma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001253","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.compbiomed.2025.110619","type":"journal-article","created":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T17:25:10Z","timestamp":1751822710000},"page":"110619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"PA","title":["A comprehensive targeted panel of 295 genes: Unveiling key disease initiating and transformative biomarkers in multiple myeloma"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4652-2376","authenticated-orcid":false,"given":"Vivek","family":"Ruhela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5364-4086","authenticated-orcid":false,"given":"Ritu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9541-1903","authenticated-orcid":false,"given":"Rupin","family":"Oberoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7752-1926","authenticated-orcid":false,"given":"Anubha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.compbiomed.2025.110619_b1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110619_b2","first-page":"340","article-title":"MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management","volume":"2005","author":"Rajkumar","year":"2005","journal-title":"ASH Educ. Program Book"},{"key":"10.1016\/j.compbiomed.2025.110619_b3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00019","article-title":"Precision medicine for relapsed multiple myeloma on the basis of an integrative multiomics approach","volume":"2","author":"Lagan\u00e0","year":"2018","journal-title":"JCO Precis. Oncol."},{"issue":"26","key":"10.1016\/j.compbiomed.2025.110619_b4","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from international myeloma working group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2025.110619_b5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40265-017-0689-1","article-title":"Immunomodulatory drugs in multiple myeloma: mechanisms of action and clinical experience","volume":"77","author":"Holstein","year":"2017","journal-title":"Drugs"},{"issue":"23","key":"10.1016\/j.compbiomed.2025.110619_b6","first-page":"2465","article-title":"Subclonal TP53 copy number is associated with prognosis in multiple myeloma","volume":"132","author":"Shah","year":"2018","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110619_b7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3324\/haematol.2019.217927","article-title":"Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma","volume":"105","author":"Mikulasova","year":"2020","journal-title":"Haematologica"},{"issue":"24","key":"10.1016\/j.compbiomed.2025.110619_b8","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1158\/1078-0432.CCR-20-2283","article-title":"Implications of MYC rearrangements in newly diagnosed multiple myeloma","volume":"26","author":"Abdallah","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.compbiomed.2025.110619_b9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-3-319-40320-5_3","article-title":"Genomic aberrations in multiple myeloma","author":"Manier","year":"2016","journal-title":"Plasma Cell Dyscrasias"},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110619_b10","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/leu.2014.70","article-title":"Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma","volume":"28","author":"Affer","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110619_b11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41375-018-0196-8","article-title":"A high-risk, double-hit, group of newly diagnosed myeloma identified by genomic analysis","volume":"33","author":"Walker","year":"2019","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110619_b12","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.jmoldx.2021.08.011","article-title":"DMG26: A targeted sequencing panel for mutation profiling to address gaps in the prognostication of multiple Myeloma","volume":"23","author":"Cutler","year":"2021","journal-title":"J. Mol. Diagn."},{"issue":"13","key":"10.1016\/j.compbiomed.2025.110619_b13","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1158\/1078-0432.CCR-21-3695","article-title":"Myeloma genome project panel is a comprehensive targeted genomics panel for molecular profiling of patients with multiple myeloma","volume":"28","author":"Sudha","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.compbiomed.2025.110619_b14","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00277-015-2344-9","article-title":"Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M 3 P)","volume":"94","author":"Kort\u00fcm","year":"2015","journal-title":"Ann. Hematol."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110619_b15","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.72","article-title":"A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma","volume":"6","author":"Bolli","year":"2016","journal-title":"Blood Cancer J."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110619_b16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41408-018-0062-y","article-title":"A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5","volume":"8","author":"White","year":"2018","journal-title":"Blood Cancer J."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110619_b17","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1021\/acs.jcim.7b00028","article-title":"DeepPPI: boosting prediction of protein\u2013protein interactions with deep neural networks","volume":"57","author":"Du","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2025.110619_b18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jtbi.2016.04.020","article-title":"Protein\u2013protein interaction inference based on semantic similarity of gene ontology terms","volume":"401","author":"Zhang","year":"2016","journal-title":"J. Theoret. Biol."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110619_b19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/bioinformatics\/btr610","article-title":"Gene ontology-driven inference of protein\u2013protein interactions using inducers","volume":"28","author":"Maetschke","year":"2012","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110619_b20","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/bioinformatics\/btac104","article-title":"Transformergo: predicting protein\u2013protein interactions by modelling the attention between sets of gene ontology terms","volume":"38","author":"Ieremie","year":"2022","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110619_b21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s42256-021-00325-y","article-title":"Integration of multiomics data with graph convolutional networks to identify new cancer genes and their associated molecular mechanisms","volume":"3","author":"Schulte-Sasse","year":"2021","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.compbiomed.2025.110619_b22","article-title":"A unified approach to interpreting model predictions","volume":"30","author":"Lundberg","year":"2017","journal-title":"Adv. Neural Inf. Process. Syst."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110619_b23","first-page":"1155","article-title":"BDL-SP: A bio-inspired DL model for the identification of altered signaling pathways in multiple myeloma using WES data","volume":"13","author":"Ruhela","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.compbiomed.2025.110619_b24","series-title":"Interim analysis of the MMRF CoMMpass trial, a longitudinal study in multiple myeloma relating clinical outcomes to genomic and immunophenotypic profiles","author":"Keats","year":"2013"},{"key":"10.1016\/j.compbiomed.2025.110619_b25","article-title":"Pytorch: An imperative style, high-performance deep learning library","volume":"32","author":"Paszke","year":"2019","journal-title":"Adv. Neural Inf. Process. Syst."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110619_b26","article-title":"A package for survival analysis in S","volume":"2","author":"Therneau","year":"2015","journal-title":"R Packag. Version"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110619_b27","doi-asserted-by":"crossref","DOI":"10.1002\/0471250953.bi1110s43","article-title":"From FastQ data to high-confidence variant calls: the genome analysis toolkit best practices pipeline","volume":"43","author":"Van der Auwera","year":"2013","journal-title":"Curr. Protoc. Bioinform."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110619_b28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-016-1029-6","article-title":"MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data","volume":"17","author":"Fan","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.compbiomed.2025.110619_b29","article-title":"Calling somatic SNVs and indels with Mutect2","author":"Benjamin","year":"2019","journal-title":"BioRxiv"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110619_b30","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110619_b31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/bioinformatics\/btr665","article-title":"SomaticSniper: identification of somatic point mutations in whole genome sequencing data","volume":"28","author":"Larson","year":"2012","journal-title":"Bioinformatics"},{"issue":"16","key":"10.1016\/j.compbiomed.2025.110619_b32","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110619_b33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bioinformatics\/btx536","article-title":"FATHMM-XF: accurate prediction of pathogenic point mutations via extended features","volume":"34","author":"Rogers","year":"2018","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110619_b34","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","article-title":"Universal patterns of selection in cancer and somatic tissues","volume":"171","author":"Martincorena","year":"2017","journal-title":"Cell"},{"issue":"D1","key":"10.1016\/j.compbiomed.2025.110619_b35","doi-asserted-by":"crossref","first-page":"D529","DOI":"10.1093\/nar\/gky1079","article-title":"The BioGRID interaction database: 2019 update","volume":"47","author":"Oughtred","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110619_b36","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1016\/j.cell.2021.04.011","article-title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome","volume":"184","author":"Huttlin","year":"2021","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110619_b37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.166835","article-title":"FunCoup 5: functional association networks in all domains of life, supporting directed links and tissue-specificity","volume":"433","author":"Persson","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.compbiomed.2025.110619_b38","first-page":"gkw985","article-title":"HIPPIE v2. 0: enhancing meaningfulness and reliability of protein\u2013protein interaction networks","author":"Alanis-Lobato","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.compbiomed.2025.110619_b39","doi-asserted-by":"crossref","first-page":"D632","DOI":"10.1093\/nar\/gkab1048","article-title":"HumanNet v3: an improved database of human gene networks for disease research","volume":"50","author":"Kim","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"6563","key":"10.1016\/j.compbiomed.2025.110619_b40","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf3067","article-title":"Interpretation of cancer mutations using a multiscale map of protein systems","volume":"374","author":"Zheng","year":"2021","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110619_b41","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/s41587-019-0298-5","article-title":"Co-regulation map of the human proteome enables identification of protein functions","volume":"37","author":"Kustatscher","year":"2019","journal-title":"Nature Biotechnol."},{"issue":"D1","key":"10.1016\/j.compbiomed.2025.110619_b42","doi-asserted-by":"crossref","first-page":"D687","DOI":"10.1093\/nar\/gkab1028","article-title":"The reactome pathway knowledgebase 2022","volume":"50","author":"Gillespie","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.compbiomed.2025.110619_b43","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110619_b44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008827","article-title":"Population genetic models of GERP scores suggest pervasive turnover of constrained sites across mammalian evolution","volume":"16","author":"Huber","year":"2020","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110619_b45","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1101\/gr.097857.109","article-title":"Detection of nonneutral substitution rates on mammalian phylogenies","volume":"20","author":"Pollard","year":"2010","journal-title":"Genome Res."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110619_b46","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1101\/gr.3715005","article-title":"Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes","volume":"15","author":"Siepel","year":"2005","journal-title":"Genome Res."},{"issue":"17","key":"10.1016\/j.compbiomed.2025.110619_b47","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr407","article-title":"Predicting the functional impact of protein mutations: application to cancer genomics","volume":"39","author":"Reva","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.110619_b48","first-page":"2825","article-title":"Scikit-learn: Machine learning in python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"key":"10.1016\/j.compbiomed.2025.110619_b49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00011","article-title":"OncoKB: a precision oncology knowledge base","volume":"1","author":"Chakravarty","year":"2017","journal-title":"JCO Precis. Oncol."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110619_b50","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","article-title":"A compendium of mutational cancer driver genes","volume":"20","author":"Mart\u00ednez-Jim\u00e9nez","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"D1","key":"10.1016\/j.compbiomed.2025.110619_b51","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110619_b52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232644","article-title":"TargetDB: A target information aggregation tool and tractability predictor","volume":"15","author":"De Cesco","year":"2020","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110619_b53","first-page":"587","article-title":"Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma","volume":"132","author":"Walker","year":"2018","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110619_b54","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1038\/s41467-019-11680-1","article-title":"Genomic landscape and chronological reconstruction of driver events in multiple myeloma","volume":"10","author":"Maura","year":"2019","journal-title":"Nat. Commun."},{"issue":"D1","key":"10.1016\/j.compbiomed.2025.110619_b55","doi-asserted-by":"crossref","first-page":"D1046","DOI":"10.1093\/nar\/gkaa1070","article-title":"The UCSC genome browser database: 2021 update","volume":"49","author":"Navarro Gonzalez","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.110619_b56","series-title":"Multiple Factor Analysis by Example Using R","author":"Pag\u00e8s","year":"2014"},{"issue":"W1","key":"10.1016\/j.compbiomed.2025.110619_b57","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110619_b58","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.90","article-title":"Gene set knowledge discovery with enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr. Protoc."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110619_b59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-14-S18-S1","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"15","key":"10.1016\/j.compbiomed.2025.110619_b60","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv474","article-title":"Haploinsufficiency predictions without study bias","volume":"43","author":"Steinberg","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110619_b61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001154","article-title":"Characterising and predicting haploinsufficiency in the human genome","volume":"6","author":"Huang","year":"2010","journal-title":"PLoS Genet."},{"issue":"D1","key":"10.1016\/j.compbiomed.2025.110619_b62","doi-asserted-by":"crossref","first-page":"D1227","DOI":"10.1093\/nar\/gkad1040","article-title":"DGIdb 5.0: rebuilding the drug\u2013gene interaction database for precision medicine and drug discovery platforms","volume":"52","author":"Cannon","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110619_b63","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1038\/leu.2012.128","article-title":"SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status","volume":"26","author":"Lopez-Corral","year":"2012","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110619_b64","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/leu.2013.199","article-title":"Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms","volume":"28","author":"Walker","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110619_b65","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3324\/haematol.2017.163766","article-title":"The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma","volume":"102","author":"Mikulasova","year":"2017","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110619_b66","first-page":"1919","article-title":"Characterizing the mutational landscape of MM and its precursor MGUS","volume":"12","author":"Farswan","year":"2022","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110619_b67","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41375-018-0206-x","article-title":"Subclonal evolution in disease progression from MGUS\/SMM to multiple myeloma is characterised by clonal stability","volume":"33","author":"Dutta","year":"2019","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110619_b68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5572-x","article-title":"Nonsynonymous, synonymous and nonsense mutations in human cancer-related genes undergo stronger purifying selections than expectation","volume":"19","author":"Chu","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110619_b69","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1038\/s41467-019-10489-2","article-title":"A pan-cancer analysis of synonymous mutations","volume":"10","author":"Sharma","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110619_b70","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/humu.23163","article-title":"Synonymous somatic variants in human cancer are not infamous: a plea for full disclosure in databases and publications","volume":"38","author":"Soussi","year":"2017","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110619_b71","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/nar\/gkaa019","article-title":"Prevalence and architecture of posttranscriptionally impaired synonymous mutations in 8,320 genomes across 22 cancer types","volume":"48","author":"Teng","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110619_b72","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2014.01.051","article-title":"Synonymous mutations frequently act as driver mutations in human cancers","volume":"156","author":"Supek","year":"2014","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.compbiomed.2025.110619_b73","first-page":"2731","article-title":"Cancer immunoediting and immune dysregulation in multiple myeloma","volume":"136","author":"Nakamura","year":"2020","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110619_b74","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.4049\/jimmunol.1701622","article-title":"Loss of the immune checkpoint CD85j\/LILRB1 on malignant plasma cells contributes to immune escape in multiple myeloma","volume":"200","author":"Lozano","year":"2018","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110619_b75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/15384101.2015.1121324","article-title":"Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors","volume":"15","author":"Kang","year":"2016","journal-title":"Cell Cycle"},{"issue":"20","key":"10.1016\/j.compbiomed.2025.110619_b76","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1158\/1078-0432.CCR-05-0456","article-title":"Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"11","author":"Leleu","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110619_b77","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1038\/leu.2016.199","article-title":"HLA polymorphism and risk of multiple myeloma","volume":"30","author":"Beksac","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.compbiomed.2025.110619_b78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-021-00781-4","article-title":"Pathophysiological role of calcium channels and transporters in the multiple myeloma","volume":"19","author":"Li","year":"2021","journal-title":"Cell Commun. Signal."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110619_b79","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1242\/jcs.115.12.2497","article-title":"RyR1 and RyR3 isoforms provide distinct intracellular Ca2+ signals in HEK 293 cells","volume":"115","author":"Rossi","year":"2002","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110619_b80","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrclinonc.2016.122","article-title":"Genomic complexity of multiple myeloma and its clinical implications","volume":"14","author":"Manier","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110619_b81","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1158\/1078-0432.CCR-10-1066","article-title":"The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells","volume":"17","author":"L\u00f3pez-Corral","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"26","key":"10.1016\/j.compbiomed.2025.110619_b82","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMcp052790","article-title":"Monoclonal gammopathy of undetermined significance","volume":"355","author":"Blad\u00e9","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.compbiomed.2025.110619_b83","first-page":"5573","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies","volume":"117","author":"Korde","year":"2011","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110619_b84","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1182\/blood.V106.11.1545.1545","article-title":"The t (4; 14) is present in patients with early stage plasma cell proliferative disorders including MGUS and smoldering multiple myeloma (SMM)","volume":"106","author":"Van Wier","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110619_b85","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3324\/haematol.2009.016329","article-title":"The t (14; 20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance","volume":"95","author":"Ross","year":"2010","journal-title":"Haematologica"},{"issue":"34","key":"10.1016\/j.compbiomed.2025.110619_b86","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1200\/JCO.2012.48.4923","article-title":"Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del (17p), t (4; 14), gain 1q, hyperdiploidy, and tumor load","volume":"31","author":"Neben","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110619_b87","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.exphem.2015.11.006","article-title":"Deletion of Rb1 induces both hyperproliferation and cell death in murine germinal center B cells","volume":"44","author":"He","year":"2016","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110619_b88","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/bmt.2009.107","article-title":"1P21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma","volume":"45","author":"Chang","year":"2010","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110619_b89","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.18632\/oncotarget.3319","article-title":"Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiomed.2025.110619_b90","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3389\/fonc.2019.01442","article-title":"Imputation of gene expression data in blood cancer and its significance in inferring biological pathways","volume":"9","author":"Farswan","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.compbiomed.2025.110619_b91","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fonc.2018.00665","article-title":"Deregulation and targeting of TP53 pathway in multiple myeloma","volume":"8","author":"Jovanovi\u0107","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.compbiomed.2025.110619_b92","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1182\/blood-2021-147400","article-title":"Disease characteristics of multiple Myeloma involving BRAF mutations","volume":"138","author":"Mohamed","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.compbiomed.2025.110619_b93","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3389\/fonc.2019.01137","article-title":"KRAS\/NRAS\/BRAF mutations as potential targets in multiple myeloma","volume":"9","author":"Pasca","year":"2019","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110619_b94","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/sj.leu.2403153","article-title":"High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis","volume":"17","author":"Liebisch","year":"2003","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110619_b95","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/gcc.20098","article-title":"Duplication of chromosome arms 9q and 11q: Evidence for a novel, 14q32 translocation\u2013independent pathogenetic pathway in multiple myeloma","volume":"42","author":"Liebisch","year":"2005","journal-title":"Genes Chromosom. Cancer"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110619_b96","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41408-019-0199-3","article-title":"Deciphering the chronology of copy number alterations in multiple myeloma","volume":"9","author":"Aktas Samur","year":"2019","journal-title":"Blood Cancer J."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110619_b97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138248","article-title":"Deletion of chromosomal region 8p21 confers resistance to bortezomib and is associated with upregulated decoy TRAIL receptor expression in patients with multiple myeloma","volume":"10","author":"Duru","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110619_b98","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41408-021-00474-8","article-title":"Chromosome 1q21 abnormalities in multiple myeloma","volume":"11","author":"Schmidt","year":"2021","journal-title":"Blood Cancer J."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110619_b99","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/j.clml.2019.09.087","article-title":"Aberrations of chromosome X in patients with multiple myeloma","volume":"19","author":"Balcarkova","year":"2019","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110619_b100","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1038\/ncomms3997","article-title":"Heterogeneity of genomic evolution and mutational profiles in multiple myeloma","volume":"5","author":"Bolli","year":"2014","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110619_b101","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1158\/0008-5472.CAN-11-2781","article-title":"Identification of molecular vulnerabilities in human multiple myeloma cells by RNA interference lethality screening of the druggable genome","volume":"72","author":"Tiedemann","year":"2012","journal-title":"Cancer Res."},{"issue":"D1","key":"10.1016\/j.compbiomed.2025.110619_b102","doi-asserted-by":"crossref","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the drug\u2013gene interaction database (DGIdb 4.0) with open crowdsource efforts","volume":"49","author":"Freshour","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.110619_b103","article-title":"Vemurafenib in patients with relapsed refractory multiple myeloma harboring BRAFV600 mutations: a cohort of the histology-independent VE-BASKET study","volume":"2","author":"Raje","year":"2018","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.compbiomed.2025.110619_b104","first-page":"1","article-title":"Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial","author":"Subbiah","year":"2023","journal-title":"Nature Med."},{"key":"10.1016\/j.compbiomed.2025.110619_b105","series-title":"National cancer institute (NCI). Targeted therapy directed by genetic testing in treating patients with advanced refractory solid tumors, lymphomas, or multiple myeloma (the MATCH screening trial). NLM identifier: NCT02465060; 2020","author":"Flaherty","year":"2015"},{"issue":"22","key":"10.1016\/j.compbiomed.2025.110619_b106","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.2169\/internalmedicine.9097-21","article-title":"Bortezomib-thalidomide-dexamethasone-cisplatin-doxorubicin-cyclophosphamide-etoposide as a salvage and bridging regimen before hematopoietic stem cell transplantation for relapsed or refractory multiple myeloma","volume":"61","author":"Togano","year":"2022","journal-title":"Intern. Med."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525009709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525009709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T08:43:24Z","timestamp":1777193004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525009709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":106,"alternative-id":["S0010482525009709"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110619","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.10.28.564536","asserted-by":"object"}]},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive targeted panel of 295 genes: Unveiling key disease initiating and transformative biomarkers in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110619"}}